225 related articles for article (PubMed ID: 20547795)
1. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
[TBL] [Abstract][Full Text] [Related]
3. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
[TBL] [Abstract][Full Text] [Related]
5. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
[TBL] [Abstract][Full Text] [Related]
6. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
[TBL] [Abstract][Full Text] [Related]
7. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Marquiño W; Huilca M; Calampa C; Falconí E; Cabezas C; Naupay R; Ruebush TK
Am J Trop Med Hyg; 2003 May; 68(5):608-12. PubMed ID: 12812355
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Avila JC; Villaroel R; Marquiño W; Zegarra J; Mollinedo R; Ruebush TK
Trop Med Int Health; 2004 Feb; 9(2):217-21. PubMed ID: 15040558
[TBL] [Abstract][Full Text] [Related]
10. Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand.
Krudsood S; Looareesuwan S; Wilairatama P; Leowattana W; Tangpukdee N; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
Trop Med Int Health; 2011 Apr; 16(4):458-65. PubMed ID: 21219551
[TBL] [Abstract][Full Text] [Related]
11. Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Na-Bangchang K; Ruengweerayut R; Wernsdorfer WH
Eur J Clin Pharmacol; 2011 Jul; 67(7):687-91. PubMed ID: 21556929
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Ramharter M; Kurth FM; Bélard S; Bouyou-Akotet MK; Mamfoumbi MM; Agnandji ST; Missinou MA; Adegnika AA; Issifou S; Cambon N; Heidecker JL; Kombila M; Kremsner PG
J Antimicrob Chemother; 2007 Nov; 60(5):1091-6. PubMed ID: 17884832
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
[TBL] [Abstract][Full Text] [Related]
15. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Rueangweerayut R; Phyo AP; Uthaisin C; Poravuth Y; Binh TQ; Tinto H; Pénali LK; Valecha N; Tien NT; Abdulla S; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
N Engl J Med; 2012 Apr; 366(14):1298-309. PubMed ID: 22475593
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Tangpukdee N; Krudsood S; Thanachartwet V; Pengruksa C; Phophak N; Kano S; Li G; Brittenham GM; Looareesuwan S; Wilairatana P
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):1-8. PubMed ID: 18567436
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Hoglund RM; Ruengweerayut R; Na-Bangchang K
Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria.
Thuy le TD; Hung le N; Hung NC; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):205-12. PubMed ID: 17539268
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Valecha N; Srivastava B; Dubhashi NG; Rao BH; Kumar A; Ghosh SK; Singh JP; Kiechel JR; Sharma B; Jullien V; Dash AP; Taylor WR; Anvikar AR
J Vector Borne Dis; 2013 Dec; 50(4):258-64. PubMed ID: 24499847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
